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Purpose/Objectives: To explore the feasibility of combined aerobic and resistance training
(CART) as a safe method of improving cardiometabolic health among cancer survivors.
Design: Descriptive and longitudinal pilot study for exercise intervention.
Setting: University campus in Los Angeles, California.
Sample: A multiethnic population of cancer survivors (N = 11) was recruited by convenience
sampling and physician referral.
Methods: Consenting participants were prescribed CART for one hour per day, three days
per week for 13 weeks.
Main Research Variables: Components of cardiometabolic health were measured, including resting heart rate (HRrest), blood pressure, body mass index, waist circumference, body
fat percentage, and android fat percentage at baseline and after 13 weeks of training. Fasting blood glucose, insulin, adiponectin, leptin, tumor necrosis factor alpha, and C-reactive
protein (CRP) also were assessed at baseline and after 13 weeks of training.
Findings: More than half of the participants reported living with at least two other chronic
diseases or conditions in addition to a cancer diagnosis. Five of six African American and
Hispanic participants reported the presence of at least two risk factors for metabolic
syndrome, compared to one of five Caucasian participants. After 13 weeks of training,
participants experienced an average decrease in waist circumference. Decrease in waist
circumference was associated with a decrease in CRP. A relationship also was suggested
between number of exercise sessions attended and improvement in HRrest.
Conclusions: A CART intervention among cancer survivors should continue to be explored
in a larger sample to establish efficacy and effectiveness at improving cardiometabolic
health. Because of the higher risk of comorbidity among cancer survivors in comparison to
cancer-free adults, improving cardiometabolic health is as important as monitoring cancer
recurrence. A need exists for increased attention to the post-treatment cardiometabolic
health of cancer survivors and also for examining potential cardiometabolic health disparities among non-Caucasian cancer survivors.
Implications for Nursing: CART may be a plausible alternative to reduce the risk of metabolic syndrome and improve cardiometabolic health among cancer survivors. Additional
studies that continue to explore the efficacy and effectiveness of CART may provide more
information to help nurses and physicians determine whether the cancer survivorship care
plan should include an exercise-based alternative to intervene on cardiometabolic health.

E

arly detection through cancer screening and the increased efficacy of
cancer treatments have improved the chances of survival among patients with cancer (Siegel et al., 2012). As of 2014, the estimated prevalence of cancer survivors in the United States was 14.5 million, with
about 64% being considered 5-year survivors and 15% being considered
20-year survivors (DeSantis et al., 2014). Cancer survivors are living longer but
with a greater comorbid burden than similarly aged individuals without cancer.
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Previous research indicates that cancer survivors
experience a higher burden of chronic disease, disability, and obesity compared to cancer-free adults
(Leach et al., 2015; Tarleton, Ryan-Ibarra, & Induni,
2014). Additional studies specifically report that longterm survivors were more likely to have risk factors
for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) in comparison to their cancer-free
counterparts (Daher, Daigle, Bhatia, & Durand, 2012;
Underwood et al., 2012; Weaver et al., 2013).
T2DM and CVD are clinically defined by poor cardiometabolic health. Cardiometabolic health is influenced
by level of adiposity and dependent on properly functioning cardiovascular and metabolic systems (see
Figure 1). Adiposity in the central region of the body,
often referred to as the android region, is particularly
associated with components of metabolic syndrome,
dyslipidemia, hypertension, and insulin resistance
(Antuna-Puente, Feve, Fellahi, & Bastard, 2008; Galic,
Oakhill, & Steinberg, 2010; Rasouli & Kern, 2008). Insulin resistance also is widely recognized as a late effect
of chemotherapy and radiation therapy (Guinan et al.,
2014; Rajendran, Abu, Fadl, & Byrne, 2013; Vergès, Walter, & Cariou, 2014). Treatment-related cardiotoxicity
and radiation-related damage to the cardiovascular
and respiratory systems also exacerbate the risk for
CVD (Ewer & Ewer, 2010; Fuchs et al., 2003).
Because metabolic syndrome strongly predisposes
patients to T2DM and CVD, it is emerging as one of
the greatest concerns of oncology practitioners. The
majority of published studies of metabolic syndrome
among cancer survivors largely have focused on
breast cancer survivors and the prevalence of obesity because of treatment-related effects on hormone
status and ability to engage in physical activity. About
40% of breast cancer survivors are overweight or
obese and, among this population, the prevalence of
metabolic syndrome ranges from 50%–55% (Buttros
Dde et al., 2013; Elme et al., 2013; Ortiz-Mendoza, dela-Fuente-Vera, & Pérez-Chávez, 2014). Obesity and
metabolic syndrome among survivors also can be
accompanied by elevated levels of C-reactive protein
(CRP), a pro-inflammatory risk factor for poor cardiovascular health (Buttros Dde et al., 2013).
One nonpharmacologic way to improve cardiometabolic health among cancer survivors is to prescribe
aerobic exercise combined with resistance training.
Moderate-intensity exercise supports health and
improves quality of life among cancer survivors by
reducing adiposity and biomarkers associated with
T2DM and CVD (Anand et al., 2011; Lin et al., 2010;
Lujan & DiCarlo, 2013). The combination of aerobic
exercise and resistance training can promote healthy
cardiovascular, endocrine, and musculoskeletal systems (Friedenreich, Neilson, & Lynch, 2010; Lee et al.,
ONCOLOGY NURSING FORUM • VOL. 43, NO. 3, MAY 2016

2012). Aerobic exercise and resistance training also
may have positive effects on resting heart rate (HRrest)
and blood pressure (BP) and may improve the cardiorespiratory health of post-treatment cancer survivors
(Midtgaard et al., 2013; Schmitz et al., 2005). In addition, regular participation in an exercise program
that includes resistance training may remediate late
effects of treatment, such as fatigue and cardiotoxicity
(Brown et al., 2011).
Previously published studies of training programs
for cancer survivors vary in the exercise prescription
and outcomes measured. Programs that prescribed
moderate-intensity exercise consistently noted significant improvements in body composition, biomarkers, or cardiovascular health (Allgayer, Nicolaus, &
Schreiber, 2004; Guinan et al., 2013; Hayes, Davies,
Parker, & Bashford, 2003; Hsieh et al., 2008), whereas
programs based on walking or low-intensity exercise
did not report measurable change in these risk factors. Although the benefits of moderate-intensity
exercise have been shown to be greater than those of
low-intensity programs, the length of the prescribed
programs and which outcomes are assessed vary. The

FIGURE 1. Clinical Determinants of Cardiometabolic
Health

•
•
•
•
•
•

Central Adiposity
Increased waist circumference
Increased android fat percentage
Increased body fat percentage
Increased leptin
Decreased adiponectin
Increased tumor necrosis factor–alpha

•
•
•
•
•

Metabolic Syndrome
Elevated triglycerides
Elevated low-density lipoprotein
Decreased high-density lipoprotein
Increased blood pressure
Increased fasting blood glucose

Type 2 Diabetes Mellitus
• Increased blood insulin
• Increased fasting blood glucose

•
•
•
•
•
•

Cardiovascular Disease
Increased resting heart rate
Elevated C-reactive protein
Elevated triglycerides
Elevated low-density lipoprotein
Decreased high-density lipoprotein
Increased blood pressure
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majority of the previously published work focuses on
weight loss or biomarkers (Allgayer et al., 2004) or on
cardiovascular health (Broderick et al., 2013; Dimeo,
Fetscher, Lange, Mertelsmann, & Keul, 1997; Hsieh et
al., 2008) as independent outcomes. To the researchers’ knowledge, only one study has approached cardiometabolic health comprehensively and assessed
the prevalence of metabolic syndrome among cancer
survivors (Guinan et al., 2013).
The purpose of this pilot implementation of the
improving physical activity after cancer treatment
(IMPAACT) study is to evaluate whether 13 weeks
of combined aerobic and resistance training (CART)
could safely and feasibly improve cardiometabolic
health and reduce comorbidities. This study also
aims to assess the feasibility of analyzing all three of
the cardiometabolic health domains (anthropometric,
functional, and biomarker) and metabolic syndrome
in the same study population as important outcomes
for an exercise training intervention.

Methods
Design
The IMPAACT study was approved by the Loyola
Marymount University (LMU) Institutional Review
Board and conducted on LMU’s Westchester campus
in Los Angeles, California. A multiethnic population of
cancer survivors responded to recruitment by convenience sampling methods, which included survey
distribution and flyers within a 15-mile radius of LMU’s
campus, physician referral, and local community electronic mailing lists. Of the 24 survivors who expressed
interest, 11 provided written consent to participate in
the feasibility study. Reasons reported by 13 survivors
for declining participation included transportation limitations, work schedules, lack of child care, and poor
health. All cancer survivors who participated in the
study provided written informed consent. Interested
survivors were excluded if they were experiencing
recurrent cancer or a new primary cancer, currently
receiving radiation or chemotherapy, had a myocardial
infarction or stroke within the past year, had lymphedema or inflammation of the pelvis or lower extremities, had a history of fainting while exercising, or had
a history of chest pain or shortness of breath brought
on by exercise. Participants were asked to inform
their physicians of their planned participation and to
review the exercise and assessment protocols with
their physicians. Eleven participants were assessed at
baseline by a registered clinical exercise physiologist
to determine whether the exercise intervention was
appropriate for their individual ability. Two participants withdrew from the study between baseline and
postintervention assessments, citing increased family
308

responsibilities. The remaining nine participants completed the 13-week intervention and the baseline and
postintervention assessments.

Data Collection
Demographic characteristics, medical history,
reproductive history, and physical activity patterns
were obtained at baseline from a self-administered
questionnaire. Cardiovascular health was assessed at
baseline and postintervention by a registered clinical
exercise physiologist as participants rested supine
for 10 minutes in a quiet environment, free of sensory
stimulation. HRrest and BP were recorded as the lowest HR during and as the average of two consecutive
measurements at the conclusion of the rest period,
respectively. Height, waist circumference, and weight
were measured by exercise physiologists using a stadiometer (cm), tape measure (cm), and digital scale
(kg), respectively, at baseline and postintervention.
Waist circumference measurements are established as
a practical, valid, and reliable method to quantify fat
in the abdominal region and predict risk for chronic
disease (Klein et al., 2007). Specifically, waist circumference was the perimeter measured at the narrowest
circumference of the body between the lowest rib and
the iliac crest. Participants wore minimal clothing, and
measurements were taken after exhaling while arms
hung freely. The tape measure, made of non-stretch
material, was placed perpendicular to the long axis
of the body with the tape snug, but not compressed,
against skin. The Aerobic Center Longitudinal Study
Physical Activity Questionnaire (Pereira et al., 1997)
was used to assess regular physical activity for three
months prior to study enrollment. This validated questionnaire is self-administered and allows for evaluation
of intensity (in metabolic equivalents) and duration
of regular physical activity (Kohl, Blair, Paffenbarger,
Macera, & Kronenfeld, 1988).
Dual-energy x-ray absorptiometry (DXA) analysis
of body composition was performed at baseline and
postintervention. DXA of the whole body was used to
quantify whole body fat percentage and fat percentage in the android body segment. The DXA analysis
software defines the android region of interest as the
approximate area around the waist between the midpoint of the lumbar spine and the superior border of
the pelvis.
Fifteen milliliters of an overnight fasting blood
sample were collected from each consenting participant by a licensed phlebotomist using venipuncture
at baseline and postintervention time points. Fasting
blood glucose (FBG) and insulin were assessed as risk
factors for T2DM (Rynders et al., 2014). Adiponectin
and leptin are adipokines produced by adipose tissue
and were assessed as risk factors for T2DM and CVD
VOL. 43, NO. 3, MAY 2016 • ONCOLOGY NURSING FORUM

(Diaz, Karlan, & Li, 2013). Tumor necrosis factor (TNF)–
alpha and CRP are biomarkers of inflammation and
were assessed as risk factors for CVD (Folsom, 2013;
van Holten et al., 2013). Blood samples were processed
at the LMU Biomedical Science laboratory by trained
laboratory technicians for serum separation, aliquoted, and stored at –80°C. Levels of insulin (intra-assay
3% coefficient of variation [CV], inter-assay 11% CV),
adiponectin (intra-assay 4% CV, inter-assay 10% CV),
leptin (intra-assay 5% CV, inter-assay 13% CV), TNFalpha (intra-assay 2.6% CV, inter-assay 13% CV), and
CRP (intra-assay < 10% CV, inter-assay < 15% CV) were
analyzed at the Norris Comprehensive Cancer Center
at the University of Southern California in Los Angeles.
FBG was assessed at the University of California, Los
Angeles Clinical and Translational Research Laboratory on an Olympus AU400® chemistry immuno-analyzer
platform (intra-assay < 2% CV, inter-assay < 3% CV).
Thresholds for biomarker assessments were set
according to expected values identified in the literature. Participants could be classified at baseline as
prediabetic based on an FBG of more than 100 mg/
dl or a fasting blood insulin level of more than the
recommended threshold of 20 mcU/ml, which is comparable to levels observed among individuals with
T2DM and metabolic syndrome (García-Jiménez et al.,
2015). Observed leptin levels of more than 20 ng/ml
are within a range associated with being overweight
or obese and insulin resistance (Zuo et al., 2013).
Adiponectin levels of less than 15 mcg/ml are associated with being overweight or obese, and CRP levels
of more than the threshold of 3 mg/L and less than
10 mg/L are considered to be at high risk for chronic
inflammation (Ridker et al., 2008).
Cardiometabolic health was defined according to
clinical criteria put forth by the National Heart, Lung,
and Blood Institute at the National Institutes of Health
(Nelms, Sucher, Lacey, & Roth, 2011). Based on these
criteria, an individual with three or more of the following cardiometabolic risk factors can be clinically
diagnosed with metabolic syndrome: a large waistline
with increased risk, defined as greater than 88 cm for
women and greater than 102 cm for men; triglyceride
level of 150 mg/dl or greater; high-density lipoprotein
cholesterol level of less than 50 mg/dl for women and
less than 40 mg/dl for men; BP of 130/85 mmHg or
greater; FBG of 100 mg/dl or greater; or currently taking
medication for high cholesterol, high BP, or high FBG.

Exercise Intervention
The IMPAACT study is a supervised CART program
prescribed for one hour per day, three days per week.
Each exercise session includes: (a) 20 minutes of cardiorespiratory training; (b) 25 minutes of circuit-style
combined resistance and cardiorespiratory training;
ONCOLOGY NURSING FORUM • VOL. 43, NO. 3, MAY 2016

TABLE 1. Sample Characteristics (N = 11)
Characteristic
Age (years)
Characteristic
Gender
Female
Male
Race/ethnicity
Caucasian
African American
Hispanic
Birthplace
California
Other country
Other state in the United States
Employment status
Employed
Retired
Education
High school
Some college
Two-year college graduate
Four-year college graduate
Cancer diagnosis
Breast
Ovarian
Colorectal
Hodgkin lymphoma
Lung
Time since treatment
Less than 1 year
1–4 years
5 years or more

X

—

SD

57.8

10.5
n
10
1
5
4
2
6
3
2
6
5
1
2
2
6
5
3
1
1
1
4
2
5

and (c) 15 minutes of core training, flexibility exercises,
and cool down. All exercise is prescribed in accordance
with the American College of Sports Medicine (ACSM)
exercise guidelines for cancer survivors (Schmitz et
al., 2010). Prescribed cardiovascular intensity is determined using the Karvonen Formula (exercise target
HR = [HR reserve] x percentage of exercise intensity +
HRrest), in combination with medical history and current level of activity and physical fitness. HR reserve
(maximal HR [HRmax] – HRrest) is a function of measured
HRrest and HRmax, the latter of which is predicted based
on participant’s age (HRmax = 220 – age).
During the CART program, cardiorespiratory training included walking or using an elliptical machine or
stationary bike to achieve an individually prescribed
target HR training zone (40%–80% of HR reserve) by
referring to an HR monitor. Circuit training included
sets of eight upper and lower body exercises. During
week 1, two sets of circuit training were performed for
two minutes for program acclimation and correction
of form, and then decreased to one minute during
week 2. Beginning with week 3, the circuit training was
309

TABLE 2. Medical History and Health Behaviors
(N = 11)
Characteristic
Prevalent chronic disease
None
1
2
3 or more
Tobacco smoking
Never
Former
Current
Alcohol consumption
Never
Former
Current
Breakfast consumption (days per week)
0
1–2
3–4
5–6
7
Group fitness
Yes
No
Missing data
Current activity level
Very good
Good
OK
Needs improvement

n
1
3
4
3
9
2
–
2
1
8
–
–
2
4
5
4
6
1
–
4
2
5

performed as three sets, with each set lasting 45 seconds, followed by a brief 20-second rest period. Core
training involved two to three exercises to improve
abdominal and trunk strength, which were accompanied by dynamic and static stretching to increase
range of motion.
The exercises involved in the resistance circuit
included different modes of upper- and lower-body
resistance training, whole-body vibration, and lateral
walking. Varied resistance or intensity was provided
with elastic resistance bands, increasing step heights
(4, 6, 8 inches), or varied body positions and body
weight for resistance. All participants were provided
customized options at each station to account for
functional or injury limitations. Whole-body vibration
was included to promote potential improvements in
muscular strength (Lau et al., 2011), bone density (Slatkovska, Alibhai, Beyene, & Cheung, 2010), and neuropathy (Kessler & Hong, 2013). Training was performed
on a Vibraflex® 550 platform (also called the Galileo®
2000). Vibration began at 30 seconds and 20 Hz for
the first four weeks of the program and progressed
to a 45-second duration at 25 Hz, with participants
performing simple movements such as heel raises and
partial squats concurrently during vibration exposure.
310

Statistical Analysis
Changes in anthropometrics, functional variables,
and biomarkers were evaluated before and after 13
weeks of training. Simple relationships were assessed
by Pearson’s correlation coefficients. All determinations were performed using SPSS®, version 18.2.

Results
Baseline Characteristics
The IMPAACT study volunteers were a multiethnic
population, with more than half of the participants
self-identifying as African American or Hispanic (see
Table 1). Participants (N = 11) were largely female
and breast cancer survivors without a history of
metastatic disease, and the average cohort age was
about 58 years. The majority of participants were less
than five years since the time of their last treatment.
The ACSM recommends at least 150 minutes of
moderate-intensity physical activity each week
(Schmitz et al., 2010). Based on responses collected
using the Aerobics Center Longitudinal Physical Activity Questionnaire (Pereira et al., 1997), at baseline,
6 of 11 participants self-reported that their regular
physical activity met ACSM guidelines. No participants were performing vigorous activity before enrollment. At baseline, two participants presented
with at least three cardiometabolic risk factors and
could have been clinically diagnosed with metabolic
syndrome (see Table 2). More than half of participants
reported gaining weight in the year prior to joining
the study, with the most frequently reported gain being 5–10 pounds.
In addition to being diagnosed with cancer, 10 participants self-reported a clinical diagnosis of at least
one other chronic disease or condition. Seven participants reported living with at least two other chronic
diseases or conditions, in addition to being a cancer
survivor. The most commonly reported chronic diseases and conditions at baseline included high BP (n =
2), thyroid conditions (n = 5), chronic bronchitis (n =
2), and osteoporosis or osteopenia (n = 2).

Cardiovascular Health and Body Composition
Cardiovascular variables, such as HRrest and BP, are
displayed in Table 3. Four of 11 participants met the
American Heart Association criteria for diagnosis of
prehypertension (Midtgaard et al., 2013). Body composition and anthropometric data are presented for
all participants and by race/ethnicity. At baseline, 5
of 11 participants were classified as overweight (body
mass index [BMI] > 25 kg/m2) and another three were
classified as obese (BMI > 30 kg/m2). When examining
waist circumference at study entry, Caucasian women
VOL. 43, NO. 3, MAY 2016 • ONCOLOGY NURSING FORUM

displayed a smaller waistline than African American
women.

Metabolic Syndrome and Biomarkers
of Cardiometabolic Health

changes in work schedules, childcare responsibilities,
temporary illness (e.g., seasonal colds), and family
vacations. Six of the 11 participants experienced a
weight gain of 5–15 pounds in the year prior to study
enrollment. Postintervention analysis showed an average decrease in waist circumference of 1.8 cm (SD
= 3.97), with three of nine participants experiencing
more than a 3 cm reduction in waist circumference.
The participants with the largest decrease in waist
circumference were also participants who attended
more than 70% of the training sessions during the 13week pilot study. As a whole, participants experienced
an 11% decrease in average fat mass of the android
body region. A trend of a decrease in android total
mass, android fat percentage, and whole body fat
percentage was seen. No significant change was observed from baseline to postintervention of HRrest or
BP. However, a relationship was found between number of sessions attended and improvement in HRrest.
No injuries were reported during the CART exercise sessions, and, during the 13-week IMPAACT
program, no harm was reported by participants from
the prescribed exercise.

Ten of 11 participants who completed the intervention provided fasting blood specimens for biomarker
analysis. One participant declined to provide a blood
specimen, citing a preexisting difficulty with giving
blood because of venous damage from chemotherapy.
At baseline, 3 of 10 participants who volunteered blood
specimens could be classified as prediabetic based on
—
an FBG of more than 100 mg/dl (X = 112 mg/dl [SD =
12]), and one participant was at increased risk for
prediabetes (FBG = 98 mg/dl). One participant had an
elevated fasting blood insulin level of 22.9 mcU/ml, and
one participant had a higher risk level of fasting blood
insulin at 18.7 mcU/ml. Two participants had slightly
increased leptin levels in the 15–20 ng/ml range, four
participants had leptin levels of more than 20 ng/ml
—
(X = 35.4 ng/ml [SD = 17.1]), and five participants had
—
adiponectin levels of less than 15 mcg/ml (X = 11 mcg/
dl [SD = 3.18]). One participant had a high-risk CRP
level of 4.66 mg/L, and one participant had
an elevated CRP level of 2.72 mg/L.
TABLE 3. Cardiovascular Health and Body Composition
After 13 weeks of training, improvements
were observed in prevalence of metabolic
Baseline
13 Weeks
syndrome and in biomarkers of cardiometa(N = 11)
(N = 9)
bolic health (see Tables 4 and 5). Decreases
—
—
X
SD
X
SD
in waist circumference were associated with Variable
2
a decrease in CRP (r = 0.692). The largest
HRrest (BPM)
decreases in CRP were observed among
Total
64.6
13.1
67.1
13
African Americans/Hispanics
66.5
16.3
73.4
11
those with the greatest android fat mass at
Caucasians
62.4
9.2
59.3
11.9
baseline (r 2 = 0.826). Number of sessions
Systolic BP (mmHg)
attended was positively correlated with deTotal
115.4
12.9
118.4
11.3
creases in insulin (r2 = 0.72) and decreases in
African Americans/Hispanics
118
12.3
125.5
4.6
leptin (r2 = 0.785). Time since last treatment
Caucasians
112.2
14.2
109.6
11.1
was positively correlated with decreases in Diastolic BP (mmHg)
Total
70.6
7
71.8
9.8
insulin levels (r2 = 0.8) and FBG (r2 = 0.757).
African Americans/Hispanics
72.5
5.1
75.7
10.8
The researchers’ analysis also suggested
Caucasians
68.4
8.9
66.9
6.5
that participants with the longest time since
Body mass index (kg/m2)
Total
26.9
3.5
26.6
3.7
last treatment experienced the greatest deAfrican Americans/Hispanics
28.8
3
29.1
3
crease in interleukin-10 levels after training
Caucasians
24.6
2.8
23.5
1.4
2
(r = 0.647). No relationships were observed
Waist circumference (cm)
between participation with adiponectin or
Total
86.7
10.4
84.9
8.8
TNF-alpha after 13 weeks of CART.
African Americans/Hispanics
89.9
6.1
89
9

Postintervention Change
in Cardiometabolic Health
Adherence to the prescribed exercise
intervention (one hour per day, three days
per week for 13 weeks, with 38 possible
sessions) ranged from 24%–97%, with an
average participation of 63% (SD = 27%). Reasons reported for missing sessions included

Caucasians
Whole body fat (%)
Total
African Americans/Hispanics
Caucasians
Android fat (%)
Total
African Americans/Hispanics
Caucasians

83.1

13.9

79.6

5.9

38.4
41.3
35.5

5.6
5.2
4.9

38
40.7
35.3

6.2
6.9
4.8

37.6
40.1
35

7.1
3
9.4

36.1
40
31.2

8.5
6.6
7.9

BP—blood pressure; BPM—beats per minute; HRrest—resting heart rate
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and prevalence of T2DM,
hyper tension, and CVD
African American
have been observed in lonCaucasian
and Hispanic
gitudinal and cross-sectionAll Participants
Participants
Participants
al comparisons of people
who are African American
Baseline
13 Weeks
Baseline
13 Weeks Baseline 13 Weeks
Risk Factors
(N = 11)
(N = 9)
(N = 5)
(N = 4)
(N = 6)
(N = 5)
and Caucasian (Brancati,
Kao, Folsom, Watson, & SzkNone
3
6
2
3
1
3
lo, 2000; Loehr et al., 2004).
1
3
2
2
1
1
1
2
3
–
–
–
3
–
Disparities in comorbid
3 or more
2
1
1
–
1
1
burden have been reported
among cancer survivors
by race/ethnicity (Allard
& Maxwell, 2009; Ashing,
Rosales,
Lai,
&
Hurria,
2014;
Haynes & Smedley, 1999;
Discussion
Tammemagi, 2007; Winnick, Gaillard, & Schuster,
The IMPAACT study explored the preliminary effi2008). Previous research established that T2DM was
cacy of an exercise prescription for CART by assessing
more prevalent among Hispanic cancer survivors,
three domains of change in cardiometabolic health:
and CVD and circulatory complications were more
anthropometric, functional, and biomarker. Through
prevalent among African American cancer survivors
cross-sectional assessment in the small sample of mul(Schultz, Stava, Beck, & Vassilopoulou-Sellin, 2004).
tiethnic cancer survivors who had completed cancer
The IMPAACT study was able to assess cardiotreatment, the researchers found that 10 participants
metabolic health in a multiethnic cohort of cancer
self-reported comorbid conditions of chronic disease.
survivors and identify potential racial disparities
In addition, two participants were found to exhibit
in prevalence of metabolic syndrome and in levels
three or more risk factors of cardiometabolic health
of biomarkers of cardiometabolic risk. In general,
and could be diagnosed with metabolic syndrome.
Caucasian female participants showed a trend for imThe researchers explored the feasibility of whether
provement in variables of cardiovascular health and
a relatively short 13-week aerobic and resistance
body composition, which was not observed in African
training intervention could influence cardiometabolic
American female participants. However, because the
health and observed patterns of improvement in the
researchers did not observe statistically significant
anthropometric, functional, and biomarker-related
disparities in this feasibility study, repeating the inrisk factors for metabolic health within the study popvestigation in a larger multiethnic population will be
ulation. Improvements in waist circumference, body
important to quantify these potential relationships
composition, and HRrest suggest that CART could be a
between race and cardiometabolic outcomes.
safe and effective method of improving cardiometaThe IMPAACT study design represents a unique shift
bolic health for cancer survivors. The relationships
toward assessing the effect of training on cardiometaobserved in this feasibility study between exercise
bolic health, as represented by a profile that includes
participation and changes in biomarkers of cardiorisk of metabolic syndrome, as well as abnormal levels
metabolic health suggest that repeating this intervenof related biomarkers. In addition, the study also is
tion with a larger sample size and longer intervention
innovative in using DXA-derived data in combination
would be worthwhile. With at least six months of
with anthropometric measures to objectively meatraining, visualizing temporal relationships between
sure android fat mass, which is particularly relevant
anthropometric and functional changes and improveto T2DM and CVD. Although individual risk factors
ments in cardiometabolic biomarkers may be possible
(e.g., BMI) are important to assess, the tendency to
(Ryan, Nicklas, Berman, & Elahi, 2003). Expanding this
assess each risk factor independent of one another
approach in a larger sample size also may allow for
as risk factors for either T2DM or CVD may focus too
the analysis of demographic characteristics as medianarrowly on long-term outcomes. This may lead to a
tors of potential temporal relationships.
missed opportunity to intervene on cardiometabolic
Because of the racial homogeneity of previously
health in the early stages of metabolic syndrome,
published studies and the observed racial disparities
which would be of great benefit to this population
in the baseline prevalence of metabolic syndrome in
of cancer survivors who already are experiencing
the current study population, a need exists for addigreater morbidity in comparison to cancer-free adults.
tional assessment of cardiometabolic health among
Collectively, the researchers’ findings suggest that
non-Caucasian cancer survivors. Differences in risk
changes in markers of cardiometabolic health may be
TABLE 4. Cardiometabolic Risk Factors Before and After Training
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associated with improvements in body composition
and cardiovascular health. These positive benefits
appear to be most salient for those who recently have
completed treatment. The findings of this feasibility
study may be of particular interest to nursing professionals who work with patients at the conclusion of
cancer treatment. Although walking is an important
activity for maintaining fitness, additional emphasis
is needed by healthcare providers on quantifying the
benefits of combined programs of aerobic exercise
and resistance training on metabolic risk factors and
remediating late treatment effects. CART also may
reduce the long-term risk for chronic disease after
cancer treatment. Continuing to explore potential
relationships between biomarkers, body composition,
and cardiovascular health in response to exercise in
larger, multiethnic populations of cancer survivors
is important.

Limitations

of longer duration may be beneficial to the cardiometabolic health of cancer survivors.

Conclusion and Implications
for Nursing
Cancer survivorship is a distinct stage of the cancer
experience and is highly dependent on sustainable
health promotion after treatment. A comprehensive
cancer survivorship plan can aid cancer survivors in
enhancing the transition from treatment to the next
life stage and improving treatment outcomes. Nurses
have an opportunity to build relationships with cancer survivors because they see the same patients
during different stages of treatment and follow-up. The
role of oncology nurses in patient education in the
areas of nutrition and lifestyle interventions has been
established by the review of international research
evidence, clinical literature, and analysis of current
policy. A need exists for enhancement of professional
guidance in nursing with regard to physical activity
so that nurses know what to safely recommend to
effectively promote good cardiometabolic health and
to know when these recommendations may be most
pertinent.
Because of prior findings and those of the current
study, oncology nurses are well positioned to deliver
guidance regarding physical activity and engagement

The current study is limited by sample size, but
it remains comparable to samples sizes reported in
seven feasibility studies of cancer survivors (Balneaves et al., 2014; Campbell et al., 2012; Cormie
et al., 2013; Frensham, Zarnowiecki, Parfitt, King, &
Dollman, 2014; Katz et al., 2010; Peddle-McIntyre,
Bell, Fenton, McCargar, & Courneya, 2012; Spector,
Deal, Amos, Yang, & Battaglini, 2014). These studies also are comparable
in the focus on piloting
in-person or group-based
exercise inter ventions TABLE 5. Biomarkers of Cardiometabolic Health Before and After Training
with the goal of addressing treatment-related effects and comorbidity.
The lack of comparison
to a control group in the
current study limits the
ability to understand
changes in cardiometabolic health after cancer
treatment without exercise. However, because
of the longitudinal design,
each participant serves
as his or her own control,
with the baseline assessment of each participant
providing a reference for
cardiometabolic health.
The shor t duration of
the exercise intervention
limits interpretation, but
small positive improvements suggest that CART

All Participants
Biomarker

Caucasian
Participants

African American
and Hispanic
Participants

X

—

SD

X

—

SD

X

—

SD

18.31
12.49
3.17
94.1
23.51
10.7

9.05
6.66
2.88
15.17
16.09
2.23

21.51
11.37
3.59
91
15.06
10.87

11.27
7.12
3.37
20.31
5.89
2.73

15.1
13.61
1.89
97.2
31.97
10.53

5.62
6.79
–
9.03
19.22
1.9

20.25
8.61
2.35
93.25
23.01
9.05

5.81
4.56
1.19
10.74
16.21
2.94

22.1
5.68
2.36
87.5
12.97
7.67

6.42
1.73
1.46
5.56
3.94
3.36

18.41
11.53
2.33
99
33.06
10.88

5.34
4.77
–
12.24
18.13
0.44

Baseline
Adiponectin (mcg/ml)
Blood insulin (mcU/ml)
C-reactive protein (mg/L)
Fasting blood glucose (mg/dl)
Leptin (ng/ml)
TNF-alpha (pg/ml)
13 weeks
Adiponectin (mcg/ml)
Blood insulin (mcU/ml)
C-reactive protein (mg/L)
Fasting blood glucose (mg/dl)
Leptin (ng/ml)
TNF-alpha (pg/ml)

TNF—tumor necrosis factor
Note. At baseline, of 11 total participants, 5 were Caucasian and 6 were African American
or Hispanic. After 13 weeks, of 8 total participants, 4 were Caucasian and 4 were African
American or Hispanic.

ONCOLOGY NURSING FORUM • VOL. 43, NO. 3, MAY 2016

313

Knowledge Translation
• Increased risk for metabolic syndrome and high prevalence
of comorbidity among cancer survivors warrant awareness
of the potential benefits of combined aerobic and resistance training (CART) among the healthcare team.
• Oncology nurses monitor patient characteristics frequently
and longitudinally and can provide American College of
Sports Medicine–based recommendations on engaging in
physical activity after treatment.
• CART could be a safe and effective way to reduce the longterm risk for chronic disease and enhance cardiometabolic
health among cancer survivors.

in regular exercise as a means of mediating T2DM and
CVD risk factors at the point of a patient’s transition
from cancer treatment to post-treatment survivorship.
The authors gratefully acknowledge the participants of
the IMPAACT study; their research collaborators, Stephanie
Perez, MS, ATC, Todd Shoepe, EdD, MS, CSCS, and Sarah
Strand, PhD, ATC; their student research assistants, Daniel
Conti, Claire Cronenweth, Isabela Kuroyama, Lacey Smith,
and Samantha Weckmann; and Danielle Good-Dawson, BA,
and Joshua Korte, BS, for their consistent administrative and
laboratory support.
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